INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,667,292 | -20.4% | 70,403 | -3.2% | 0.01% | -15.4% |
| Q2 2023 | $4,604,820 | +10.9% | 72,723 | -5.2% | 0.01% | +8.3% |
| Q1 2023 | $4,152,330 | -8.0% | 76,682 | -10.1% | 0.01% | -20.0% |
| Q4 2022 | $4,513,653 | +13.8% | 85,292 | +0.1% | 0.02% | +15.4% |
| Q3 2022 | $3,966,000 | -21.7% | 85,231 | -3.9% | 0.01% | 0.0% |
| Q2 2022 | $5,062,000 | -21.7% | 88,674 | -16.1% | 0.01% | 0.0% |
| Q1 2022 | $6,468,000 | +23.8% | 105,700 | +5.9% | 0.01% | +30.0% |
| Q4 2021 | $5,224,000 | +39.0% | 99,800 | -1.0% | 0.01% | +25.0% |
| Q3 2021 | $3,758,000 | -8.8% | 100,800 | -0.1% | 0.01% | -11.1% |
| Q2 2021 | $4,119,000 | +20.3% | 100,900 | 0.0% | 0.01% | +28.6% |
| Q1 2021 | $3,424,000 | +4.2% | 100,900 | -2.3% | 0.01% | -12.5% |
| Q4 2020 | $3,285,000 | +26.7% | 103,300 | +2.3% | 0.01% | +33.3% |
| Q3 2020 | $2,592,000 | +10.3% | 101,000 | +10.3% | 0.01% | -14.3% |
| Q2 2020 | $2,351,000 | +88.1% | 91,600 | +12.7% | 0.01% | +75.0% |
| Q1 2020 | $1,250,000 | -43.9% | 81,300 | +25.3% | 0.00% | -33.3% |
| Q4 2019 | $2,227,000 | +359.2% | 64,900 | 0.0% | 0.01% | +500.0% |
| Q3 2019 | $485,000 | -42.4% | 64,900 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $842,000 | +15.3% | 64,900 | +8.3% | 0.00% | 0.0% |
| Q1 2019 | $730,000 | +38.8% | 59,900 | +29.7% | 0.00% | 0.0% |
| Q4 2018 | $526,000 | -46.9% | 46,200 | +1.3% | 0.00% | -33.3% |
| Q3 2018 | $990,000 | +22.8% | 45,600 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $806,000 | +59.6% | 45,600 | +90.0% | 0.00% | +100.0% |
| Q1 2018 | $505,000 | +45.1% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $348,000 | -8.2% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $379,000 | +27.2% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $298,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |